Acta pharmaceutica Hungarica最新文献

筛选
英文 中文
Analytical Comparison of Infliximab and Related Biosimilars 英夫利昔单抗与相关生物类似药的分析比较
Acta pharmaceutica Hungarica Pub Date : 2021-11-15 DOI: 10.33892/aph.2021.91.184
M. Malinao, Morgen Kramer, Chad Elchman, B. Rivera, S. Orlowicz, Helko Behr
{"title":"Analytical Comparison of Infliximab and Related Biosimilars","authors":"M. Malinao, Morgen Kramer, Chad Elchman, B. Rivera, S. Orlowicz, Helko Behr","doi":"10.33892/aph.2021.91.184","DOIUrl":"https://doi.org/10.33892/aph.2021.91.184","url":null,"abstract":"","PeriodicalId":6941,"journal":{"name":"Acta pharmaceutica Hungarica","volume":"21 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2021-11-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"78054107","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A HILIC-MS/MS Method for the Structural Analysis of Human Alpha-1-Acid Glycoprotein 人α -1-酸性糖蛋白结构分析的HILIC-MS/MS方法
Acta pharmaceutica Hungarica Pub Date : 2021-11-15 DOI: 10.33892/aph.2021.91.330-331
Dávid Virág, T. Kremmer, Zsófia Huba, Adina Borbély, Gitta Schlosser, B. Dalmadi Kiss, I. Antal, I. Klebovich, K. Ludányi
{"title":"A HILIC-MS/MS Method for the Structural Analysis of Human Alpha-1-Acid Glycoprotein","authors":"Dávid Virág, T. Kremmer, Zsófia Huba, Adina Borbély, Gitta Schlosser, B. Dalmadi Kiss, I. Antal, I. Klebovich, K. Ludányi","doi":"10.33892/aph.2021.91.330-331","DOIUrl":"https://doi.org/10.33892/aph.2021.91.330-331","url":null,"abstract":"","PeriodicalId":6941,"journal":{"name":"Acta pharmaceutica Hungarica","volume":"11 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2021-11-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"88245746","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Application of Automated Ultrasound Signal Generator in the Development of Electrospun Multi-Layered Polymeric Nanofibrous Structures 自动超声信号发生器在电纺丝多层聚合物纳米纤维结构开发中的应用
Acta pharmaceutica Hungarica Pub Date : 2021-11-15 DOI: 10.33892/aph.2021.91.260-261
Arle Kõrkjas, Ivo Laidmäe, Karin Kogermann, A. Salmi, H. Nieminen, E. Hæggström, J. Heinämäki
{"title":"Application of Automated Ultrasound Signal Generator in the Development of Electrospun Multi-Layered Polymeric Nanofibrous Structures","authors":"Arle Kõrkjas, Ivo Laidmäe, Karin Kogermann, A. Salmi, H. Nieminen, E. Hæggström, J. Heinämäki","doi":"10.33892/aph.2021.91.260-261","DOIUrl":"https://doi.org/10.33892/aph.2021.91.260-261","url":null,"abstract":"to generate nanofibrous","PeriodicalId":6941,"journal":{"name":"Acta pharmaceutica Hungarica","volume":"70 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2021-11-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"86251008","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Determination of Amino Sugars in Blood Serum Samples by RP-HPLC Method 反相高效液相色谱法测定血清中氨基糖的含量
Acta pharmaceutica Hungarica Pub Date : 2021-11-15 DOI: 10.33892/aph.2021.91.226-227
R. Góra, M. Hutta, Erik Beňo
{"title":"Determination of Amino Sugars in Blood Serum Samples by RP-HPLC Method","authors":"R. Góra, M. Hutta, Erik Beňo","doi":"10.33892/aph.2021.91.226-227","DOIUrl":"https://doi.org/10.33892/aph.2021.91.226-227","url":null,"abstract":"","PeriodicalId":6941,"journal":{"name":"Acta pharmaceutica Hungarica","volume":"19 6","pages":""},"PeriodicalIF":0.0,"publicationDate":"2021-11-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"91474652","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Insights for a Risk-Assessment Tool to Manage Medicines’ Shortages 管理药品短缺的风险评估工具的见解
Acta pharmaceutica Hungarica Pub Date : 2021-11-15 DOI: 10.33892/aph.2021.91.308-309
U. Musazzi, Domenico Di Giorgio, P. Minghetti
{"title":"Insights for a Risk-Assessment Tool to Manage Medicines’ Shortages","authors":"U. Musazzi, Domenico Di Giorgio, P. Minghetti","doi":"10.33892/aph.2021.91.308-309","DOIUrl":"https://doi.org/10.33892/aph.2021.91.308-309","url":null,"abstract":"","PeriodicalId":6941,"journal":{"name":"Acta pharmaceutica Hungarica","volume":"269 1-4","pages":""},"PeriodicalIF":0.0,"publicationDate":"2021-11-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"91509029","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Evaluation of a Pneumatic Tube System for Delivering Nivolumab Diluted Solutions 用于输送纳武单抗稀释溶液的气动管道系统的评估
Acta pharmaceutica Hungarica Pub Date : 2021-11-15 DOI: 10.33892/aph.2021.91.306-307
F. Selmin, L. Camuffo, Francesca Vasile, Greta Mangoni, Mariantonietta Piccoli, M. Rivano, L. Cancanelli, P. Minghetti
{"title":"Evaluation of a Pneumatic Tube System for Delivering Nivolumab Diluted Solutions","authors":"F. Selmin, L. Camuffo, Francesca Vasile, Greta Mangoni, Mariantonietta Piccoli, M. Rivano, L. Cancanelli, P. Minghetti","doi":"10.33892/aph.2021.91.306-307","DOIUrl":"https://doi.org/10.33892/aph.2021.91.306-307","url":null,"abstract":"","PeriodicalId":6941,"journal":{"name":"Acta pharmaceutica Hungarica","volume":"17 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2021-11-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"83225945","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Assigning the components of a Self-Nanoemulsifying Drug Delivery System (SNEDDs) of Deferasirox 去铁氧胺自纳米乳化给药系统(SNEDDs)的组分分配
Acta pharmaceutica Hungarica Pub Date : 2021-11-15 DOI: 10.33892/aph.2021.91.287-289
Alaa Alghananim, Y. Özalp, B. Mesut, Y. Özsoy, S. Güngör
{"title":"Assigning the components of a Self-Nanoemulsifying Drug Delivery System (SNEDDs) of Deferasirox","authors":"Alaa Alghananim, Y. Özalp, B. Mesut, Y. Özsoy, S. Güngör","doi":"10.33892/aph.2021.91.287-289","DOIUrl":"https://doi.org/10.33892/aph.2021.91.287-289","url":null,"abstract":"Deferasirox (DFR) is an oral tridentate iron chelator effective for reduction of body iron in ironoverloaded patients with transfusion-dependent anemias [1]. It is a highly lipophilic molecule (log P: 3.52) which is classified as BCS Class II drug substance [2]. Self-nanoemulsifying drug delivery systems (SNEDDs) are isotropic mixtures of drug, oil and hydrophilic surfactants and co-surfactant/co-solvents. In recent years, SNEDDs gained more attention in the solubility enhancement of lipophilic molecule hence enhancing their oral bioavailability. The selection of appropriate components in the SNEDDs formulation is crucial for development of a successful formulation. The goal of this work is to select and to screen appropriate components for the optimization of DFR loaded SNEDDs formulations. In this respect, different SNEDDs formulations were prepared and pseudo-ternary phase diagrams were constructed. 2. Materials and Methods","PeriodicalId":6941,"journal":{"name":"Acta pharmaceutica Hungarica","volume":"90 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2021-11-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"85227245","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
ADMET in Drug Development: What is the Role of Animals between In Silico : In vitro and In Vivo Humans? ADMET在药物开发中的作用:动物在体外和体内的作用是什么?
Acta pharmaceutica Hungarica Pub Date : 2021-11-15 DOI: 10.33892/aph.2021.91.144-145
O. Pelkonen
{"title":"ADMET in Drug Development: What is the Role of Animals between In Silico : In vitro and In Vivo Humans?","authors":"O. Pelkonen","doi":"10.33892/aph.2021.91.144-145","DOIUrl":"https://doi.org/10.33892/aph.2021.91.144-145","url":null,"abstract":"Traditionally, experimental animal studies have constituted a backbone of drug development, in particular in toxicity evaluation. Almost from the beginning of modern drug development the reliance on animal experiments has been critisised on various grounds, from obvious differences between animals and humans to the emergence of 3R principles (refine, reduce, replace). Increasingly, in vitro methodologies have paved the way for more mechanistic and molecular approaches and, even more recently, the application of computational methods have provided platforms for simulating and integrating various approaches. Indeed, some circles even anticipate a more or less rapid disappearance of animal experiments (unless the question is about the animals’ own health and disease) or at least their replacement for a majority of current purposes by combined in vitro and in silico approaches. It is useful to remember some arguments related to this topic: 1. Variability is a fact of life at all levels of biological organization, be it a population or a gene. 2. Animals are different from humans and thus unreliable predictors without extensive focussed investigations (interspecies differences). 3. ’In vivo at an individual level’ constitutes such a complex whole that ’in vivo at a general (group, population etc) level’ could provide only approximate predictions (interindividual differences). 4. In vitro-methods can provide answers only to rather specific and well-understood and researched problems (in vitro-in vivo correlations). 5. in silico-tools, especially at a higher level of simulations and machine learning, have to be interpreted and explained in the end at the level of bioscience language and concepts (in this case pharmacology and toxicology). On the basis of the above arguments one might think that animal studies in drug development (as an example) are not very useful and the reason they are still a prominent part of DD has more to do with historical inertia than with a real necessity. Quite contrary, the use of experimental animals under proper ethical and scientific conditions offers still useful, sometimes absolutely necessary information for the advancement of drug development. In the following, some examples to illustrate this point are briefly described. Regulatory animal studies on toxicology and toxicokinetics constitute a general framework for understanding in vivo effects and behaviour of new chemical entities (NCE) including adverse effects in various bodily functions and organs and in the fate of a specific NCE in a whole organism. Currently the first kinetic study informs on mass balance, extent of absorption and elimination, metabolism, principal metabolites etc, all of which provide an initial view and comprehension of (toxico)kinetic characteristics of an NCE. This view is certainly of importance in the planning of future kinetic studies and in the interpretation of toxicity profile of an NCE. Currently in vitro studies in human-derived syst","PeriodicalId":6941,"journal":{"name":"Acta pharmaceutica Hungarica","volume":"22 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2021-11-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"75125197","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Therapeutic Relevance of Drug-loaded Electrospun Nanofiber-based Ophthalmic Inserts 载药电纺纳米纤维眼科植入物的治疗意义
Acta pharmaceutica Hungarica Pub Date : 2021-11-15 DOI: 10.33892/aph.2021.91.282-283
S. Omer, R. Zelkó
{"title":"Therapeutic Relevance of Drug-loaded Electrospun Nanofiber-based Ophthalmic Inserts","authors":"S. Omer, R. Zelkó","doi":"10.33892/aph.2021.91.282-283","DOIUrl":"https://doi.org/10.33892/aph.2021.91.282-283","url":null,"abstract":"","PeriodicalId":6941,"journal":{"name":"Acta pharmaceutica Hungarica","volume":"1 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2021-11-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"82034347","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Metabolomic Characterization of Newest Designer Drugs 最新设计药物的代谢组学特征
Acta pharmaceutica Hungarica Pub Date : 2021-11-15 DOI: 10.33892/aph.2021.91.185-186
T. Körmöczi, P. Kovács, Éva Sija, L. Institóris, É. Kereszty, I. Ilisz, R. Berkecz
{"title":"Metabolomic Characterization of Newest Designer Drugs","authors":"T. Körmöczi, P. Kovács, Éva Sija, L. Institóris, É. Kereszty, I. Ilisz, R. Berkecz","doi":"10.33892/aph.2021.91.185-186","DOIUrl":"https://doi.org/10.33892/aph.2021.91.185-186","url":null,"abstract":"","PeriodicalId":6941,"journal":{"name":"Acta pharmaceutica Hungarica","volume":"19 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2021-11-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"81848051","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信